EFFICACY OF HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM AN ALTERNATIVE DONOR ON THE PLATFORM OF TRANSPLANT CELL MODELING TECHNOLOGY IN PATIENTS WITH PRIMARY IMMUNODEFICIENCIES